Search Results 601-610 of 21344 for anti-TNF drugs

  1. Loteprednol (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Loteprednol is also used for short-term treatment of the signs and symptoms of dry eye disease. This medicine is available only with your doctor's prescription.

  2. Sumatriptan And Naproxen (Oral Route) Precautions - Mayo Clinic

    Using too much of this medicine or any other migraine medicines (eg, ergotamine, triptans, opioids, or a combination treatment for 10 or more days per month) ...

  3. Eating disorder treatment: Know your options - Mayo Clinic

    Depending on your eating disorder and its symptoms, treatment may include a mix of talk therapy, nutrition education and medicines.

  4. Ciltacabtagene Autoleucel (Intravenous Route) Precautions - Mayo Clinic

    If you can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. This medicine may cause cytokine release ...

  5. Atenolol (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Neratinib (Oral Route) Proper Use - Mayo Clinic

    Continue taking these medicines for 2 cycles (56 days) of treatment with neratinib. Keep the number of your bowel movements at 1 to 2 per day and take anti- ...

  7. Acyclovir (Oral Route, Intravenous Route) Description and Brand Names - Mayo Clinic

    Acyclovir belongs to the family of medicines called antivirals, which are used to treat infections caused by viruses. Usually these medicines work for only one ...

  8. Sulfamethoxazole And Trimethoprim (Oral Route) Precautions - Mayo Clinic

    The results of some tests may be affected by this medicine. Patients receiving anticonvulsant treatment (medicines to prevent seizures) may be at risk for a ...

  9. Investigational Oral Drug Combo Shows Promise for Newly Diagnosed Multiple Myeloma in Mayo Clinic-Led Study

    "Ixazomib is an investigational, oral proteasome inhibitor with promising anti-myeloma effects and low rates of peripheral neuropathy," says Shaji Kumar, M.D., ...

  10. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

    This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.